下一代测序揭示子宫平滑肌瘤中差异表达的小非编码RNA
在因良性指征行子宫切除术的女性中,采用下一代测序与qRT-PCR确认,比较子宫平滑肌瘤与配对子宫肌层的小非编码RNA表达谱;发现15个snoRNA、24个piRNA、7个tRNA和6个rRNA差异表达,并证实5个snoRNA上调、4个piRNA及1个tRNA、1个rRNA下调,AGO2在肌瘤中丰度更高。
要点
- 与配对子宫肌层相比,子宫平滑肌瘤中5个snoRNA上调,4个piRNA、1个tRNA和1个rRNA下调(P<.05)。
- 除SNORD30外,所验证sncRNA的表达模式未检测到月经周期依赖性差异。
- AGO2在子宫平滑肌瘤中丰度高于配对子宫肌层。
核心结论
- 结果首次提供额外类别sncRNA及AGO2在子宫平滑肌瘤中差异表达的证据,提示其作为基因调控机制的作用。
研究设计与样本
- 实验室研究,在学术中心对因良性指征行子宫切除术的女性进行。
- 采用下一代测序及sncRNA数据库筛选,并以qRT-PCR在20对配对组织中进行确认。
主要发现
- 筛选鉴定出15个snRNA、284个snoRNA、98个piRNA、152个tRNA和45个rRNA,其中15个snoRNA、24个piRNA、7个tRNA和6个rRNA在肌瘤与肌层比较中以1.5倍变化阈值差异表达。
- qRT-PCR证实子宫平滑肌瘤中SNORD30、SNORD27、SNORA16A、SNORD46和SNORD56上调,piR-1311、piR-16677、piR-20365、piR-4153、TRG-GCC5-1和RNA5SP202下调(P<.05)。
- 所验证sncRNA的表达模式与RNA测序分析相似,除SNORD30外未检测到月经周期依赖性差异。
- AGO2在子宫平滑肌瘤中丰度高于配对子宫肌层。
关键数值与推荐
- 差异表达阈值:1.5倍变化。
- qRT-PCR确认的差异表达均P<.05。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the expression profile of small noncoding RNAs (sncRNAs) in leiomyoma, which has not been investigated to date. DESIGN: Laboratory-based investigation. SETTING: Academic center. PATIENT(S): Women undergoing hysterectomy for benign indications. INTERVENTION(S): Next-generation sequencing and screening of an sncRNA database with confirmatory analysis by quantitative reverse-transcription polymerase chain reaction (qRT-PCR). MAIN OUTCOME MEASURE(S): Expression profile of sncRNAs in leiomyoma and matched myometrium. RESULT(S): Screening our previously determined RNA sequencing data with the sncRNA database resulted in identification of 15 small nuclear (sn) RNAs, 284 small nucleolar (sno) RNAs, 98 Piwi-interacting (pi) RNAs, 152 transfer (t) RNAs, and 45 ribosomal (r) RNAs, of which 15 snoRNAs, 24 piRNAs, 7 tRNAs, and 6 rRNAs were differentially expressed at a 1.5-fold change cutoff in leiomyoma compared with myometrium. We selected 5 snoRNAs, 4 piRNAs, 1 tRNA, and 1 rRNA that were differentially expressed and confirmed their expression in paired tissues (n = 20) from both phases of the menstrual cycle with the use of qRT-PCR. The results indicated up-regulation of the snoRNAs (SNORD30, SNORD27, SNORA16A, SNORD46, and SNORD56) and down-regulation of the piRNAs (piR-1311, piR-16677, piR-20365, piR-4153), tRNA (TRG-GCC5-1), and rRNA (RNA5SP202) expression in leiomyoma compared with myometrium (P<.05). The pattern of expression of these sncRNAs was similar to RNA sequencing analysis, with no menstrual cycle-dependent differences detected except for SNORD30. Because Argonaute 2 (AGO2) is required for sncRNA-mediated gene silencing, we determined its expression and found greater abundance in leiomyoma. CONCLUSION(S): Our results provide the first evidence for the differential expression of additional classes of sncRNAs and AGO2 in leiomyoma, implicating their roles as a gene regulatory mechanism.
引用
- Chuang TD, Xie Y, Yan W, et al. Next-generation sequencing reveals differentially expressed small noncoding RNAs in uterine leiomyoma. Fertil Steril. 2018. PMID: 29778390. doi:10.1016/j.fertnstert.2018.01.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。